Advertisement
Canada markets open in 3 hours 38 minutes
  • S&P/TSX

    21,885.38
    +11.66 (+0.05%)
     
  • S&P 500

    5,048.42
    -23.21 (-0.46%)
     
  • DOW

    38,085.80
    -375.12 (-0.98%)
     
  • CAD/USD

    0.7327
    +0.0004 (+0.05%)
     
  • CRUDE OIL

    83.91
    +0.34 (+0.41%)
     
  • Bitcoin CAD

    87,916.46
    +707.57 (+0.81%)
     
  • CMC Crypto 200

    1,392.84
    -3.69 (-0.26%)
     
  • GOLD FUTURES

    2,360.60
    +18.10 (+0.77%)
     
  • RUSSELL 2000

    1,981.12
    -14.31 (-0.72%)
     
  • 10-Yr Bond

    4.7060
    +0.0540 (+1.16%)
     
  • NASDAQ futures

    17,732.25
    +164.75 (+0.94%)
     
  • VOLATILITY

    15.64
    +0.27 (+1.76%)
     
  • FTSE

    8,117.79
    +38.93 (+0.48%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     
  • CAD/EUR

    0.6821
    0.0000 (0.00%)
     

Insys Therapeutics: Performance and Estimates for Q3

Insys Therapeutics: Performance and Estimates for Q3

Insys Therapeutics (INSY) is a specialty pharmaceuticals company focused on developing cannabinoids and sprays. It reported EPS of -$0.37 on revenues of $23.47 million in the second quarter of 2018.